D Horstkotte
Overview
Explore the profile of D Horstkotte including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
197
Citations
864
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bogunovic N, Horstkotte D, Faber L, Bogunovic L, Van Buuren F
Minerva Cardioangiol
. 2015 Jun;
63(5):458-9.
PMID: 26112279
No abstract available.
2.
3.
Kaller M, Faber L, Bogunovic N, Horstkotte D, Burchert W, Lindner O
Clin Res Cardiol
. 2015 Apr;
104(10):843-9.
PMID: 25893568
Background: Ultrasound guided cardiac shock wave therapy (CSWT) is a noninvasive therapeutic option in the treatment of chronic-refractory angina. Clinical trials have shown that CSWT reduces angina symptoms, improves regional...
4.
Horstkotte D, Piper C
Herz
. 2015 Mar;
40(2):265-278.
PMID: 25822422
Colonization of native cardiac valves or polymer implants, e.g. valves, conduits, rings, electrode leads and polymer-associated endocarditis (PIE), by microorganisms, primarily gram-positive bacteria (infective endocarditis), constitutes a severe, prognostically unfavorable...
5.
Wiemer M, Kottmann T, Starrach M, Horstkotte D, Nolker G
Herzschrittmacherther Elektrophysiol
. 2015 Mar;
26(2):141-7.
PMID: 25808237
Introduction: In Germany, about 1 million people are affected by atrial fibrillation (AF). Morbidity and mortality are high especially due to the risk of thromboembolic events. A valid risk stratification...
6.
Mellwig K, Schatton C, Biermann B, Kottmann T, Horstkotte D, Van Buuren F
Clin Res Cardiol Suppl
. 2015 Feb;
10:33-8.
PMID: 25666917
The clinical relevance of lipoprotein(a) (Lp(a)) as a cardiovascular risk factor is currently underestimated. The aim of our study was to assess the influence of increased Lp(a) values on the...
7.
Fox H, Puehler T, Schulz U, Bitter T, Horstkotte D, Oldenburg O
Transplant Proc
. 2014 Sep;
46(7):2462-3.
PMID: 25242802
Background: Sleep-disordered breathing (SDB), especially central sleep apnea with Cheyne-Stokes respiration (CSA-CSR), is highly prevalent in patients with severe heart failure (HF). SDB, and predominantly CSR, may improve after recovery...
8.
Mannebach H, Hamm C, Horstkotte D
Z Kardiol
. 2014 Apr;
91(9):727-9.
PMID: 24682271
No abstract available.
9.
Fox H, Oldenburg O, Nolker G, Horstkotte D, Gutleben K
Herz
. 2014 Mar;
39(1):32-6.
PMID: 24638158
Sleep-disordered breathing (SDB) represents a common comorbidity in cardiac patients. The prevalence of obstructive sleep apnea (OSA) and central sleep apnea (CSA) is very high, particularly in patients with heart...
10.
Spiesshofer J, Horstkotte D, Oldenburg O
Herz
. 2014 Feb;
39(1):90-3.
PMID: 24515301
No abstract available.